Development and Assessment of Objective Surveillance Definitions for Nonventilator Hospital-Acquired Pneumonia

Ji, Wenjing; McKenna, Caroline; Ochoa, Aileen; Batlle, Haiyan Ramirez; Young, Jessica; Rhee, Chanu; Clark, Roger; Shenoy, Erica S.; Hooper, David C.

doi:10.1001/jamanetworkopen.2019.13674

Cited by 33 publications

(51 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Automatic detection of HAP patients, based on oxygenation drop and antibiotic use, has recently been proposed [7] and may facilitate identification.…”

Section: J O U R N a L P R E -P R O O Fmentioning

confidence: 99%

Incidence and impact of hospital-acquired pneumonia: a Portuguese nationwide four-year study

Pereira

Mergulhão

Nunes

et al. 2021

Journal of Hospital Infection

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

“…Automatic detection of HAP patients, based on oxygenation drop and antibiotic use, has recently been proposed [7] and may facilitate identification.…”

Section: J O U R N a L P R E -P R O O Fmentioning

confidence: 99%

Incidence and impact of hospital-acquired pneumonia: a Portuguese nationwide four-year study

Pereira

Mergulhão

Nunes

et al. 2021

Journal of Hospital Infection

View full text Add to dashboard Cite

show abstract

“…In order to reduce the burden of nosocomial pneumonia [55], the development of new criteria to improve hospital surveillance and identify patients with HAP [56] subtypes are promising tools to monitor and investigate such disease. New molecular diagnostic techniques will allow a rapid identification of the microbiological aetiology in presence of clinical suspicion of nosocomial pneumonia.…”

Section: Future Perspectivesmentioning

confidence: 99%

Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?

et al. 2020

View full text Add to dashboard Cite

IntroductionNosocomial pneumonia develops after ≥48 h of hospitalisation and is classified as ventilator-associated pneumonia (VAP) and hospital-acquired pneumonia (HAP); the latter may require mechanical ventilation (V-HAP) or not (NV-HAP).Main findingsVAP and HAP affect a significant proportion of hospitalised patients and are characterised by poor clinical outcomes. Among them, V-HAP has the greatest 28-day mortality rate followed by VAP and NV-HAP (27.8% versus 18% versus 14.5%, respectively). However, no differences in terms of pathophysiology, underlying microbiological pathways and subsequent therapy have been identified. International guidelines suggest specific flow charts to help clinicians in the therapeutic management of such diseases; however, there are no specific recommendations beyond VAP and HAP classification. HAP subtypes are scarcely considered as different entities and the lack of data from the clinical scenario limits any final conclusion. Hopefully, recent understanding of the pathophysiology of such diseases, as well as the discovery of new therapies, will improve the outcome associated with such pulmonary infections.ConclusionNosocomial pneumonia is a multifaced disease with features of pivotal interest in critical care medicine. Due to the worrisome data on mortality of patients with nosocomial pneumonia, further prospective studies focused on this topic are urgently needed.

show abstract

“…An exciting development in NV-HAP surveillance is described by Ji et al 20 The authors conducted a cohort study in acute care hospitals that assessed multiple surveillance strategies using various combinations of easily abstracted clinical parameters for outcome measures and NV-HAP diagnosis. The authors proposed a surveillance definition that includes worsening oxygenation, administration of a new antibiotic for a minimum of 3 days, fever or abnormal white blood cell count (less than 4,000/mcL or more than 12,000/mcL), and chest imaging order.…”

Section: Measurement Of the Efficacy Of Improvement Initiatives And Strategiesmentioning

confidence: 99%

Non-ventilator health care-associated pneumonia (NV-HAP): The infection preventionist's role in identifying NV-HAP

Sposato

2020

American Journal of Infection Control

View full text Add to dashboard Cite

One of the fundamental challenges in nonventilator health care-associated pneumonia (NV-HAP) surveillance is identifying cases and standardizing surveillance protocols. This section highlights clinical pneumonia definitions and current surveillance definitions, as well as the difficulty in case finding methodologies. In addition, we review current microbiology and molecular testing methods. Further, we explore future opportunities to leverage the electronic health care record in attempt to identify a reliable less burdensome data identification and collection methodology. Finally, we highlight the importance of a collaborative approach to prevention of NV-HAP, as well as strategies to assist the IP with facilitating interdisciplinary communication and uptake of evidence-based implementation strategies.

show abstract

Development and Assessment of Objective Surveillance Definitions for Nonventilator Hospital-Acquired Pneumonia

Cited by 33 publications

References 43 publications

Incidence and impact of hospital-acquired pneumonia: a Portuguese nationwide four-year study

Incidence and impact of hospital-acquired pneumonia: a Portuguese nationwide four-year study

Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?

Non-ventilator health care-associated pneumonia (NV-HAP): The infection preventionist's role in identifying NV-HAP

Contact Info

Product

Resources

About